SCHEMBL6204213

SCHEMBL6204213

COCOC[CH]c1cccc(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.45
CHRM5 P08912 1/20 0.42
XDH P47989 2/20 0.40
CYP1A2 P05177 4/20 0.40
CYP2C19 P33261 2/20 0.40
HPGD P15428 1/20 0.40
CHAT P28329 1/20 0.39
NFE2L2 Q16236 3/20 0.38
CYP2C9 P11712 1/20 0.38
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
KMT2A Q03164 1/20 0.37
EGFR P00533 1/20 0.36
FBP1 P09467 1/20 0.36
ALOX5 P09917 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16953020 0.86 RELA (0.50) RELACHRM5XDHCYP1A2CYP2C19
SCHEMBL6205403 0.80 CHRM5 (0.50) RELACHRM5CYP1A2NFE2L2FBP1
SCHEMBL6204838 0.80 ALDH1A1 (0.47) XDHMAPTEGFR
SCHEMBL6205455 0.76 KDM4E (0.48) RELACHRM5CYP1A2CYP2C19MAPT
SCHEMBL6203320 0.76 RELA (0.47) RELACHRM5XDHCYP1A2CYP2C19
SCHEMBL1989041 0.74 CHRM5 (0.54) RELACHRM5CYP1A2CYP2C19CHAT
SCHEMBL295147 0.71 CHRM5 (0.50) RELACHRM5CYP1A2CYP2C19CHAT
SCHEMBL23457217 0.69 CHRM5 (0.52) RELACHRM5CYP1A2CYP2C19CHAT
SCHEMBL8702984 0.69 CHRM5 (0.52) RELACHRM5CYP1A2CYP2C19CHAT
SCHEMBL1759558 0.69 CHRM5 (0.52) RELACHRM5CYP1A2CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed